YHB Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.42M Buy
37,440
+489
+1% +$105K 0.6% 45
2026
Q1
$8.04M Buy
36,951
+358
+1% +$79.4K 0.58% 49
2025
Q4
$8.36M Buy
36,593
+690
+2% +$157K 0.58% 46
2025
Q3
$8.31M Sell
35,903
-309
-0.9% -$62.9K 0.61% 42
2025
Q2
$6.72M Buy
36,212
+30
+0.1% +$5.58K 0.52% 54
2025
Q1
$7.58M Sell
36,182
-504
-1% -$98K 0.63% 42
2024
Q4
$6.52M Buy
36,686
+3,352
+10% +$616K 0.54% 47
2024
Q3
$6.58M Sell
33,334
-86
-0.3% -$16.1K 0.55% 45
2024
Q2
$5.73M Sell
33,420
-1,181
-3% -$196K 0.49% 50
2024
Q1
$6.3M Sell
34,601
-693
-2% -$119K 0.56% 48
2023
Q4
$5.47M Sell
35,294
-2,405
-6% -$351K 0.53% 49
2023
Q3
$5.62M Sell
37,699
-647
-2% -$95K 0.52% 54
2023
Q2
$5.17M Sell
38,346
-1,847
-5% -$271K 0.48% 56
2023
Q1
$6.41M Buy
40,193
+937
+2% +$143K 0.64% 43
2022
Q4
$6.34M Buy
39,256
+212
+0.5% +$32.5K 0.68% 42
2022
Q3
$5.24M Buy
39,044
+501
+1% +$71.9K 0.58% 49
2022
Q2
$5.9M Buy
38,543
+501
+1% +$76.6K 0.62% 46
2022
Q1
$6.17M Buy
38,042
+2,733
+8% +$397K 0.54% 51
2021
Q4
$4.78M Buy
35,309
+894
+3% +$106K 0.38% 69
2021
Q3
$3.71M Buy
34,415
+1,655
+5% +$189K 0.32% 88
2021
Q2
$3.69M Buy
32,760
+1,321
+4% +$149K 0.31% 89
2021
Q1
$3.39M Buy
31,439
+8,326
+36% +$891K 0.29% 90
2020
Q4
$2.48M Buy
23,113
+536
+2% +$51.5K 0.24% 102
2020
Q3
$1.98M Sell
22,577
-23,378
-51% -$2.2M 0.21% 104
2020
Q2
$4.51M Buy
45,955
+273
+0.6% +$24K 0.65% 47
2020
Q1
$3.48M Buy
45,682
+1,417
+3% +$121K 0.6% 51
2019
Q4
$3.92M Sell
44,265
-1,018
-2% -$84.5K 0.56% 55
2019
Q3
$3.43M Sell
45,283
-1,507
-3% -$103K 0.52% 56
2019
Q2
$3.4M Sell
46,790
-1,025
-2% -$80.6K 0.54% 55
2019
Q1
$3.85M Sell
47,815
-1,530
-3% -$125K 0.6% 52
2018
Q4
$4.55M Sell
49,345
-180
-0.4% -$15.8K 0.81% 41
2018
Q3
$4.68M Sell
49,525
-121
-0.2% -$11.5K 0.71% 44
2018
Q2
$4.6M Buy
49,646
+23,566
+90% +$2.3M 0.75% 41
2018
Q1
$2.47M Buy
26,080
+144
+0.6% +$15.8K 0.42% 75
2017
Q4
$2.51M Buy
25,936
+165
+0.6% +$15.6K 0.43% 76
2017
Q3
$2.29M Sell
25,771
-24,537
-49% -$1.87M 0.41% 76
2017
Q2
$3.65M Buy
50,308
+347
+0.7% +$23.3K 0.63% 52
2017
Q1
$3.29M Sell
49,961
-2,368
-5% -$149K 0.63% 52
2016
Q4
$3.28M Sell
52,329
-1,378
-3% -$84.1K 0.68% 50
2016
Q3
$3.39M Buy
53,707
+10,282
+24% +$666K 0.82% 42
2016
Q2
$2.69M Sell
43,425
-478
-1% -$29.1K 0.59% 57
2016
Q1
$2.51M Buy
43,903
+520
+1% +$29K 0.68% 48
2015
Q4
$2.57M Buy
43,383
+1,550
+4% +$89.3K 0.58% 54
2015
Q3
$2.28M Buy
41,833
+39
+0.1% +$2.54K 0.54% 59
2015
Q2
$2.81M Buy
41,794
+27,210
+187% +$1.78M 0.61% 56
2015
Q1
$854K Buy
14,584
+1,280
+10% +$77.3K 0.19% 109
2014
Q4
$871K Buy
13,304
+225
+2% +$14.2K 0.2% 109
2014
Q3
$755K Buy
13,079
+1,555
+13% +$86.3K 0.18% 108
2014
Q2
$650K Buy
11,524
+615
+6% +$32.3K 0.16% 111
2014
Q1
$561K Buy
10,909
+440
+4% +$22.2K 0.14% 112
2013
Q4
$553K Hold
10,469
0.15% 108
2013
Q3
$468K Sell
10,469
-242
-2% -$10.7K 0.14% 113
2013
Q2
$443K Buy
+10,711
New +$468K 0.14% 116

Other funds holding ABBV

YHB Investment Advisors's ABBV Position: Q2 2026 in Review

YHB Investment Advisors increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $105K and bringing the position to 37,440 shares worth $9.42M. The position accounts for 0.6% of the portfolio, ranked #45.

YHB Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • YHB Investment Advisors held 37,440 shares of AbbVie worth $9.42M as of Q2 2026.
  • YHB Investment Advisors bought 489 AbbVie shares in Q2 2026, an estimated $105K.
  • AbbVie made up 0.6% of YHB Investment Advisors's portfolio in Q2 2026, its #45 holding.
  • YHB Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.